Get started
Author

Hanzhe Zheng

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
2013 · Remo Panaccione, Subrata Ghosh, et al. · Gastroenterology · 962
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19
2022 · Anil Gupta, Yaneicy Gonzalez-Rojas, et al. · JAMA · 270
PDF
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin
2010 · Stefan Wirth, Carmen Ribes-Koninckx, et al. · Journal of Hepatology · 144
Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial
2011 · Remo Panccione, Subrata Ghosh, et al. · Gastroenterology · 119
Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies
2019 · Lori Mayer, Ludwig Kappos, et al. · Multiple Sclerosis and Related Disorders · 100
Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States
2018 · Sumanta Kumar Pal, Jean Hoffman-Censits, et al. · European Urology · 26
502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab
2021 · Anil K Gupta, Yaneicy Gonzalez Rojas, et al. · Open Forum Infectious Diseases · 18
PDF
Effect of the Neutralizing SARS-CoV-2 Antibody Sotrovimab in Preventing Progression of COVID-19: A Randomized Clinical Trial
2021 · Anil Gupta, Yaneicy Gonzalez-Rojas, et al. · medRxiv · 17
PDF
S455 Efficacy and Safety of the Selective Sphingosine 1-Phosphate Receptor Modulator, Etrasimod, in Adult Patients With Eosinophilic Esophagitis: Primary Results From the Phase 2 VOYAGE Study
2023 · Evan S. Dellon, Margaret H. Collins, et al. · The American Journal of Gastroenterology · 11
Impact of Ocrelizumab on Cognition in Patients at Increased Risk of Progressive Disease (P1.420)
2018 · Ralph Benedict, Jerome De Seze, et al. · Neurology · 11
Interim Analysis of the OBOE (Ocrelizumab Biomarker Outcome Evaluation) Study in Multiple Sclerosis (MS) (S24.002)
2018 · Amit Bar-Or, Jeffrey Gelfand, et al. · Neurology · 5
Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study
2019 · Kerry A. Rogers, Michael A. Boxer, et al. · Blood · 4
635 Efficacy and Safety of the Selective Sphingosine 1-phosphate Receptor Modulator, Etrasimod, in Adult Patients With Eosinophilic Esophagitis Over 52 Weeks in the Phase 2 Voyage Study
2024 · Evan S. Dellon, Margaret H. Collins, et al. · Gastroenterology · 3
Atezolizumab (atezo) in special populations: Analyses from an expanded access program (EAP) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC).
2018 · Jean H. Hoffman-Censits, Sumanta K. Pal, et al. · Journal of Clinical Oncology · 1
Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Safety analysis from an expanded access study.
2017 · Joaquim Bellmunt, Sumanta K. Pal, et al. · Journal of Clinical Oncology · 1
Efficacy Benefits Of Fingolimod 0.5 mg Once Daily In Patients Previously Treated With Glatiramer Acetate: Pooled Analysis Of The Phase 3, Placebo-Controlled FREEDOMS and FREEDOMS II Studies In Relapsing Multiple Sclerosis (P3.193)
2014 · Douglas Jeffrey, Ernst-Wilhelm Radue, et al. · Neurology · 1
Improvement in Patient Quality of Life during Treatment with Infliximab, Azathioprine, or Combination Infliximab+Azathioprine for Moderate-to-severe Ulcerative Colitis
2013 · Remo Panaccione, Subrata Ghosh, et al. · The American Journal of Gastroenterology · 1
Baseline Characteristics of the CHORDS Study Population: A Phase III Trial to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With RRMS Who Had Disease Activity With Prior Disease-Modifying Therapies (P6.370)
2018 · Anthony Reder, Robert Bermel, et al. · Neurology
PM413. Metabolic Syndrome in Patients With Schizophrenia Receiving Long-Term Treatment With Lurasidone, Quetiapine XR, or Risperidone
2016 · John W. Newcomer, MD, Michael Tocco, PhD, et al. · The International Journal of Neuropsychopharmacology
Works count: 19
Citation count: 1,694
H-index: 10
I10-index: 10
Year
Topic
Type